Saito, Takuya
Yamashita, Yushiro
Tomoda, Akemi
Okada, Takashi
Umeuchi, Hideo
Iwamori, Saki http://orcid.org/0000-0002-0096-4673
Shinoda, Satoru
Mizuno-Yasuhira, Akiko
Urano, Hidetoshi
Nishino, Izumi
Saito, Kazuhiko
Funding for this research was provided by:
Taisho Pharmaceutical Company
Article History
Received: 17 April 2020
Accepted: 27 October 2020
First Online: 10 November 2020
Ethics approval and consent to participate
: These two clinical trials have been performed in accordance with the Declaration of Helsinki. The institutional review board for each site approved the study protocol (Additional file InternalRef removed), and all patients and/or legal guardians provided written informed consent for study participation. This study was carried out following the CONSORT guidelines and the TREND Checklist.
: Not Applicable.
: The study was funded by Taisho Pharmaceutical co., ltd. and several of the authors are affiliated with this company. Other authors (Takuya Saito, Yushiro Yamashita, Akemi Tomoda, Takashi Okada, Kazuhiko Saito) are medical adviser of this study and received advice fees from Taisho Pharmaceutical co., ltd. based on contract, and Akemi Tomoda is an Editorial Board Member of BMC Psychiatry.